Media Kit
Includes our Foundation Backgrounder, general information on Prostate Cancer, and much more.
Contact Us
For Additional Information send an email to press@pcf.org or call (310) 570-4722
Brand Identity
Approved logos and messaging.
Cleveland Clinic Researchers Validate Link Between Genetic Variant and Poor Outcomes in Men with Advanced Prostate Cancer
February 13, 2020, CLEVELAND: In a new Cleveland Clinic-led study published in JAMA Oncology, researchers...
THE PROSTATE CANCER FOUNDATION RECRUITS NBA AND NHL TEAMS TO JOIN FORCES FOR THE 2ND ANNUAL PCF BLACK HISTORY MONTH ASSIST CHALLENGE
LOS ANGELES, Calif., February 4, 2020 – The Prostate Cancer Foundation (PCF) has drafted teams...
Andrea K. Miyahira, PhD
BREAKING NEWS: FDA approves enzalutamide for metastatic castration-sensitive prostate cancer
December 16, 2019 – Today the U.S. Food and Drug Administration (FDA) approved a new...
Winship study sheds light on immune control of cancer
Issued by: Emory University Woodruff Health Sciences Center New findings could provide doctors with vital...
Cleveland Clinic Researchers Validate Link Between Genetic Variant and Poor Outcomes in Men with Advanced Prostate Cancer
February 13, 2020, CLEVELAND: In a new Cleveland Clinic-led study published in JAMA Oncology, researchers...
THE PROSTATE CANCER FOUNDATION RECRUITS NBA AND NHL TEAMS TO JOIN FORCES FOR THE 2ND ANNUAL PCF BLACK HISTORY MONTH ASSIST CHALLENGE
LOS ANGELES, Calif., February 4, 2020 – The Prostate Cancer Foundation (PCF) has drafted teams...
A Legacy of Leadership
Explore PCF's growth and impact over 25 years of funding the most promising prostate cancer research.
About our Work
Our goal is to put ourselves out of business, and we will not stop until not another man dies of prostate cancer.
Twitter Feed
Facebook Feed